Clinical Trials Browser

Phase 3 × Thromboembolism × Dalteparin × Clear all

NCT00031837 2015-10-14

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Phase 3 Terminated

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

NCT00519805 2011-08-08

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thromboembolism